UK markets open in 6 hours 36 minutes

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.80-0.01 (-0.09%)
At close: 04:00PM EDT
5.78 -0.01 (-0.26%)
After hours: 06:48PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate-0.21-0.22-1.11-0.97
Low estimate-0.25-0.3-1.37-1.3
High estimate-0.14-0.13-0.83-0.55
Year ago EPS-0.26-0.01-1.02-1.11
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7787
Avg. Estimate16.03M16.73M66.94M78.88M
Low estimate15.1M15.1M60.44M70.03M
High estimate17M17.5M71.64M88M
Year ago salesN/AN/A58.44M66.94M
Sales growth (year/est)N/AN/A14.50%17.80%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.3-0.29-0.3-0.19
Actual EPS-0.26-0.01-0.35-0.49
Difference0.040.28-0.05-0.3
Surprise %13.30%96.60%-16.70%-157.90%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.21-0.22-1.11-0.97
7 days ago-0.21-0.22-1.11-0.97
30 days ago-0.2-0.23-0.84-0.88
60 days ago-0.16-0.17-0.68-0.81
90 days ago-0.22-0.22-0.92-0.82
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesOCULIndustrySector(s)S&P 500
Current qtr.19.20%N/AN/AN/A
Next qtr.-2,100.00%N/AN/AN/A
Current year-8.80%N/AN/AN/A
Next year12.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A